These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19601728)
1. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral. Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728 [TBL] [Abstract][Full Text] [Related]
2. Development of a sublingual allergy vaccine for grass pollinosis. Frati F; Scurati S; Puccinelli P; David M; Hilaire C; Capecce M; Marcucci F; Incorvaia C Drug Des Devel Ther; 2010 Jul; 4():99-105. PubMed ID: 20689696 [TBL] [Abstract][Full Text] [Related]
3. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
5. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma. Bahceciler NN; Cobanoglu N Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885 [TBL] [Abstract][Full Text] [Related]
8. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609 [TBL] [Abstract][Full Text] [Related]
9. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126 [TBL] [Abstract][Full Text] [Related]
10. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635 [TBL] [Abstract][Full Text] [Related]
11. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Tahamiler R; Saritzali G; Canakcioglu S Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861 [TBL] [Abstract][Full Text] [Related]
13. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407 [TBL] [Abstract][Full Text] [Related]
14. One century of allergen-specific immunotherapy for respiratory allergy. Incorvaia C; Frati F Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092 [TBL] [Abstract][Full Text] [Related]
15. Advances in upper airway diseases and allergen immunotherapy. Nelson HS J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis]. Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? Nelson HS J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Panzner P; Petrás M; Sýkora T; Lesná I Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463 [TBL] [Abstract][Full Text] [Related]
20. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results. Esch RE; Bush RK; Peden D; Lockey RF Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]